Alessia Muzi

1.3k total citations
28 papers, 816 citations indexed

About

Alessia Muzi is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Alessia Muzi has authored 28 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Alessia Muzi's work include PARP inhibition in cancer therapy (13 papers), DNA Repair Mechanisms (7 papers) and Genetic factors in colorectal cancer (5 papers). Alessia Muzi is often cited by papers focused on PARP inhibition in cancer therapy (13 papers), DNA Repair Mechanisms (7 papers) and Genetic factors in colorectal cancer (5 papers). Alessia Muzi collaborates with scholars based in Italy, France and United States. Alessia Muzi's co-authors include Grazia Graziani, Lucio Tentori, Annalisa Susanna Dorio, Pedro Miguel Lacal, Carlo Leonetti, Federica Ruffini, Matteo Vergati, Marco Scarsella, Pierluigi Navarra and Patrizia Vernole and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Alessia Muzi

28 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alessia Muzi Italy	17	492	422	115	83	56	28	816
Bettina Hanstein Germany	17	635 1.3×	283 0.7×	115 1.0×	23 0.3×	89 1.6×	30	1.2k
Joana Couto Portugal	12	439 0.9×	454 1.1×	79 0.7×	37 0.4×	65 1.2×	26	959
Jocelyn Reader United States	16	331 0.7×	295 0.7×	194 1.7×	38 0.5×	39 0.7×	30	916
Michael Hansbury United States	12	396 0.8×	221 0.5×	176 1.5×	22 0.3×	26 0.5×	18	860
T Sethi United Kingdom	17	542 1.1×	422 1.0×	98 0.9×	40 0.5×	42 0.8×	37	1.1k
Martín Monte Argentina	19	869 1.8×	287 0.7×	292 2.5×	22 0.3×	36 0.6×	28	1.2k
Andrey Frolov United States	17	477 1.0×	351 0.8×	62 0.5×	22 0.3×	56 1.0×	30	1.1k
María F. Mercogliano Argentina	15	326 0.7×	344 0.8×	169 1.5×	32 0.4×	35 0.6×	23	793
Melanie Wong United States	17	418 0.8×	156 0.4×	105 0.9×	55 0.7×	35 0.6×	23	830
Cheh Peng Lim Singapore	10	635 1.3×	658 1.6×	330 2.9×	46 0.6×	155 2.8×	11	1.3k

Countries citing papers authored by Alessia Muzi

Since Specialization

Citations

This map shows the geographic impact of Alessia Muzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessia Muzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessia Muzi more than expected).

Fields of papers citing papers by Alessia Muzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessia Muzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessia Muzi. The network helps show where Alessia Muzi may publish in the future.

Co-authorship network of co-authors of Alessia Muzi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessia Muzi. A scholar is included among the top collaborators of Alessia Muzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessia Muzi. Alessia Muzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Conforti, Antonella, Mirco Compagnone, Fabio Palombo, et al.. (2023). A linear DNA encoding the SARS-CoV-2 receptor binding domain elicits potent immune response and neutralizing antibodies in domestic cats. Molecular Therapy — Methods & Clinical Development. 28. 238–248. 5 indexed citations

Graziani, Grazia, Simona Artuso, Anastasia De Luca, et al.. (2015). A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib. Biochemical Pharmacology. 95(1). 16–27. 31 indexed citations

Tentori, Lucio, Lucia Ricci‐Vitiani, Alessia Muzi, et al.. (2014). Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide. BMC Cancer. 14(1). 65 indexed citations

Tesauro, Cinzia, Grazia Graziani, Laura Zuccaro, et al.. (2014). Mutations of human DNA topoisomerase I at poly(ADP-ribose) binding sites: modulation of camptothecin activity by ADP-ribose polymers. Journal of Experimental & Clinical Cancer Research. 33(1). 71–71. 3 indexed citations

Tentori, Lucio, Alessia Muzi, Annalisa Susanna Dorio, et al.. (2013). MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination. Cancer Chemotherapy and Pharmacology. 72(1). 117–125. 13 indexed citations

Martire, Sara, Andrea Fuso, Dante Rotili, et al.. (2013). PARP-1 Modulates Amyloid Beta Peptide-Induced Neuronal Damage. PLoS ONE. 8(9). e72169–e72169. 71 indexed citations

Lacal, Pedro Miguel, Maria Grazia Petrillo, Federica Ruffini, et al.. (2013). Glucocorticoid-Induced Tumor Necrosis Factor Receptor Family-Related Ligand Triggering Upregulates Vascular Cell Adhesion Molecule-1 and Intercellular Adhesion Molecule-1 and Promotes Leukocyte Adhesion. Journal of Pharmacology and Experimental Therapeutics. 347(1). 164–172. 26 indexed citations

Tentori, Lucio, Carlo Leonetti, Alessia Muzi, et al.. (2013). Influence of MLH1 on colon cancer sensitivity to poly(ADP-ribose) polymerase inhibitor combined with irinotecan. International Journal of Oncology. 43(1). 210–218. 11 indexed citations

Caporali, Simona, Lauretta Levati, Grazia Graziani, et al.. (2012). NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug. Journal of Translational Medicine. 10(1). 252–252. 33 indexed citations

10.

Tentori, Lucio, Alessia Muzi, Annalisa Susanna Dorio, et al.. (2010). Pharmacological Inhibition of Poly(ADP-ribose) Polymerase (PARP) Activity in PARP-1 Silenced Tumour Cells Increases Chemosensitivity to Temozolomide and to a N3-Adenine Selective Methylating Agent. Current Cancer Drug Targets. 10(4). 368–383. 16 indexed citations

11.

Fiorani, P, Cinzia Tesauro, Giordano Mancini, et al.. (2009). Evidence of the crucial role of the linker domain on the catalytic activity of human topoisomerase I by experimental and simulative characterization of the Lys681Ala mutant. Nucleic Acids Research. 37(20). 6849–6858. 26 indexed citations

12.

Vernole, Patrizia, Alessia Muzi, Antonio Volpi, et al.. (2009). Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 664(1-2). 39–47. 8 indexed citations

13.

Tentori, Lucio, Alessia Muzi, Annalisa Susanna Dorio, et al.. (2008). Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity. European Journal of Cancer. 44(9). 1302–1314. 37 indexed citations

14.

Tentori, Lucio, Pedro Miguel Lacal, Alessia Muzi, et al.. (2007). Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis. European Journal of Cancer. 43(14). 2124–2133. 124 indexed citations

15.

Graziani, Grazia, Lucio Tentori, Alessia Muzi, et al.. (2006). Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype. Molecular and Cellular Endocrinology. 264(1-2). 44–49. 46 indexed citations

16.

Tentori, Lucio, Carlo Leonetti, Marco Scarsella, et al.. (2006). Inhibition of poly(ADP‐ribose) polymerase prevents irinotecan‐induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma. The FASEB Journal. 20(10). 1709–1711. 74 indexed citations

17.

Tentori, Lucio, Carlo Leonetti, Marco Scarsella, et al.. (2005). Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide. European Journal of Cancer. 41(18). 2948–2957. 40 indexed citations

18.

Tentori, Lucio, Matteo Vergati, Alessia Muzi, et al.. (2005). Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs. International Journal of Oncology. 27(2). 525–35. 29 indexed citations

19.

Lapidus, Rena G., Lucio Tentori, Grazia Graziani, et al.. (2005). Oral administration of PARP inhibitor GPI 18180 increases the anti-tumor activity of temozolomide against intracranial melanoma in mice. Journal of Clinical Oncology. 23(16_suppl). 3136–3136. 8 indexed citations

20.

Tentori, Lucio, Olindo Forini, Alessia Muzi, et al.. (2004). N3-Methyladenine Induces Early Poly(ADP-Ribosylation), Reduction of Nuclear Factor-κB DNA Binding Ability, and Nuclear Up-Regulation of Telomerase Activity. Molecular Pharmacology. 67(2). 572–581. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact